NCT03135899View on ClinicalTrials.gov

BI 443651 Methacholine Challenge

PHASE1CompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

May 18, 2017

Primary Completion Date

February 7, 2018

Study Completion Date

February 21, 2018

Conditions
Asthma
Interventions
DRUG

BI 443651

Three doses, each 12 hours apart

DRUG

Placebo

Three doses, each 12 hours apart

Trial Locations (1)

M23 9QZ

The Medicines Evaluation Unit, Manchester

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY